Allurion Technologies logo — Allurion was founded in 2009 with one mission: end obesity.

Allurion Technologies

Allurion was founded in 2009 with one mission: end obesity.

Founded 2009 United States Natick, United States 236 employees Post-IPO Equity Total: $218.36M Health Care, Health and Wellness +1

General Information

Company Name Allurion Technologies
Founded Year 2009
Location United States Natick, United States
Employees 236
Industries Health Care, Health and Wellness, Medical Devices
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Allurion Technologies. To contact Allurion Technologies, visit allurion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Allurion Technologies compare?

A PDF of Allurion Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Allurion Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Allurion Technologies

Allurion Technologies is a healthcare startup that was founded in 2009 with the mission to "end obesity." The company's innovative approach, the Allurion Program, integrates medical, digital, and nutritional methods to assist individuals in kick-starting their weight loss journey and adopting lifelong healthy habits. Having made a significant impact, with over 100,000 balloons placed and over 1,000,000kg lost worldwide, Allurion has already assisted thousands of people in achieving their weight loss goals and transforming their lives. The company is headquartered in the United States. Notably, Allurion secured a $48.00M Post-IPO Debt investment from Fortress Investment Group on 17 April 2024, showcasing continued investor interest and confidence in the company's mission and potential.

Business keywords: Medical technology, Digital health, Weight loss program, Obesity treatment, Healthcare innovation, Lifestyle modification, Nutritional coaching, Balloon weight loss, Health tech, Obesity management, Start-up success, Global impact, Public health initiative

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $20.00M 1
RTW Investments
28 Jun 2024
Post IPO Debt $48.00M 1
Fortress Investment Group
17 Apr 2024
Post IPO Equity $122.51K -
21 Dec 2023
Series D $34.00M 3
Romulus Capital, Novalis LifeSciences +1
01 Jul 2021
Debt Financing $25.00M 2
10x Capital, Runway Growth Capital
06 Apr 2021
Venture Round $34.00M 4
Romulus Capital, IDO Investments +2
07 Jan 2020
Series C $27.00M 4
Romulus Capital, IDO Investments +2
11 Jul 2017
Venture Round $19.02M -
03 Feb 2017
Venture Round $6.00M 1
Romulus Capital
18 May 2016
Venture Round $1.62M -
31 Jul 2014

View All 13 Funding Rounds

Allurion Technologies Alternatives & Competitors

View All Alternatives
Allurion Technologies vs

America’s premier weight-loss and metabolic health-solutions company.

Post-IPO Equity
38 employees
Biotechnology, Health Care
Allurion Technologies vs

Weight care, made easy!

Pre-Seed
67 employees
Health Care, Health and Wellness
Allurion Technologies vs
Spatz Medical
Spatz Medical United States

Spatz3, the World's first and only Adjustable Gastric Balloon.

20 employees
Health Care, Manufacturing

FAQ About Allurion Technologies

Allurion was founded in 2009 with one mission: end obesity.
Allurion Technologies was founded in 2009.
Allurion Technologies is headquartered in Natick, United States.
Allurion Technologies operates in Health Care, Health and Wellness and Medical Devices. Its work centres on Medical technology, Digital health, Weight loss program and Obesity treatment.
Allurion Technologies has approximately 236 employees.
Allurion Technologies has completed 13 funding rounds, raising a total of $218.36M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Allurion Technologies include ReShape Lifesciences Inc., Elevate Now, Spatz Medical , Calibrate, Embla. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Allurion Technologies and ReShape Lifesciences Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Allurion Technologies, https://bouncewatch.com/company/allurion-technologies, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes